- Home
- WWD vs RGEN Comparison
WWD vs RGEN Comparison
Compare WWD & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWD
- RGEN
- Stock Information
- Founded
- WWD 1870
- RGEN 1981
- Country
- WWD United States
- RGEN United States
- Employees
- WWD N/A
- RGEN N/A
- Industry
- WWD Industrial Machinery/Components
- RGEN Medical/Dental Instruments
- Sector
- WWD Energy
- RGEN Health Care
- Exchange
- WWD Nasdaq
- RGEN Nasdaq
- Market Cap
- WWD 9.7B
- RGEN 8.2B
- IPO Year
- WWD N/A
- RGEN N/A
- Fundamental
- Price
- WWD $163.14
- RGEN $140.00
- Analyst Decision
- WWD Buy
- RGEN Buy
- Analyst Count
- WWD 9
- RGEN 10
- Target Price
- WWD $180.75
- RGEN $188.38
- AVG Volume (30 Days)
- WWD 400.1K
- RGEN 783.2K
- Earning Date
- WWD 07-29-2024
- RGEN 10-29-2024
- Dividend Yield
- WWD 0.61%
- RGEN N/A
- EPS Growth
- WWD 80.33
- RGEN N/A
- EPS
- WWD 5.98
- RGEN N/A
- Revenue
- WWD $3,246,831,000.00
- RGEN $602,354,000.00
- Revenue This Year
- WWD $13.77
- RGEN $0.08
- Revenue Next Year
- WWD $4.22
- RGEN $12.97
- P/E Ratio
- WWD $27.32
- RGEN N/A
- Revenue Growth
- WWD 16.90
- RGEN N/A
- 52 Week Low
- WWD $119.03
- RGEN $110.45
- 52 Week High
- WWD $188.35
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- WWD 49.86
- RGEN 41.03
- Support Level
- WWD $159.59
- RGEN $138.80
- Resistance Level
- WWD $168.00
- RGEN $150.72
- Average True Range (ATR)
- WWD 4.22
- RGEN 5.04
- MACD
- WWD 0.60
- RGEN -1.06
- Stochastic Oscillator
- WWD 47.06
- RGEN 8.50
About WWD Woodward Inc.
Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and service reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company holds production and assembly facilities primarily in the United States, Europe, and Asia, and promotes products and services through worldwide locations.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.